317 related articles for article (PubMed ID: 20109651)
61. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
[TBL] [Abstract][Full Text] [Related]
62. Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency.
Kreuz W; Meili E; Peter-Salonen K; Haertel S; Devay J; Krzensk U; Egbring R
Transfus Apher Sci; 2005 Jun; 32(3):247-53. PubMed ID: 15919240
[TBL] [Abstract][Full Text] [Related]
63. Fibrinogen concentrate--a potential universal hemostatic agent.
Fenger-Eriksen C; Ingerslev J; Sørensen B
Expert Opin Biol Ther; 2009 Oct; 9(10):1325-33. PubMed ID: 19645632
[TBL] [Abstract][Full Text] [Related]
64. Thromboembolic events in patients with severe inherited fibrinogen deficiency.
Rottenstreich A; Lask A; Schliamser L; Zivelin A; Seligsohn U; Kalish Y
J Thromb Thrombolysis; 2016 Aug; 42(2):261-6. PubMed ID: 26712130
[TBL] [Abstract][Full Text] [Related]
65. Paradoxical bleeding and thrombosis in a patient with afibrinogenemia and fibrinogen Mumbai mutation.
Mukaddam A; Patil R; Jadli A; Chandrakala S; Ghosh K; Shetty S
Am J Clin Pathol; 2015 May; 143(5):755-7. PubMed ID: 25873512
[TBL] [Abstract][Full Text] [Related]
66. Severe congenital dysfibrinogenemia (fibrinogen-Riyadh): a family study.
al-Fawaz IM; Gader AM
Acta Haematol; 1992; 88(4):194-7. PubMed ID: 1292308
[TBL] [Abstract][Full Text] [Related]
67. Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion.
Platè M; Asselta R; Spena S; Spreafico M; Fagoonee S; Peyvandi F; Tenchini ML; Duga S
Blood Cells Mol Dis; 2008; 41(3):292-7. PubMed ID: 18676163
[TBL] [Abstract][Full Text] [Related]
68. Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo.
Kotlín R; Reicheltová Z; Suttnar J; Salaj P; Hrachovinová I; Riedel T; Malý M; Oravec M; Kvasnicka J; Dyr JE
J Thromb Thrombolysis; 2010 Oct; 30(3):311-8. PubMed ID: 20640913
[TBL] [Abstract][Full Text] [Related]
69. Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias.
Hill M; Dolan G
Haemophilia; 2008 Sep; 14(5):889-97. PubMed ID: 18564189
[TBL] [Abstract][Full Text] [Related]
70. Pregnancy-related thrombosis in a woman with congenital afibrinogenemia: a report of two successful pregnancies.
Roqué H; Stephenson C; Lee MJ; Funai EF; Popiolek D; Kim E; Hart D
Am J Hematol; 2004 Jul; 76(3):267-70. PubMed ID: 15224364
[TBL] [Abstract][Full Text] [Related]
71. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
Terasawa F; Kani S; Hongo M; Okumura N
Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498
[TBL] [Abstract][Full Text] [Related]
72. Fibrinogen replacement therapy for congenital fibrinogen deficiency.
Bornikova L; Peyvandi F; Allen G; Bernstein J; Manco-Johnson MJ
J Thromb Haemost; 2011 Sep; 9(9):1687-704. PubMed ID: 21711446
[TBL] [Abstract][Full Text] [Related]
73. Congenital dysfibrinogenemia in major surgery: A description of four cases and review of the literature.
Yan J; Luo M; Xiang L; Wu Y; Lin F
Clin Chim Acta; 2022 Mar; 528():1-5. PubMed ID: 35063457
[TBL] [Abstract][Full Text] [Related]
74. Fibrinogen deficiency in a dog - a case report.
Jolivet F; Diquélou A; Trumel C; Privat S; Dossin O
BMC Vet Res; 2017 Jun; 13(1):183. PubMed ID: 28629414
[TBL] [Abstract][Full Text] [Related]
75. The amplitude of coagulation curves from thrombin time tests allows dysfibrinogenemia caused by the common mutation FGG-Arg301 to be distinguished from hypofibrinogenemia.
Jacquemin M; Vanlinthout I; Van Horenbeeck I; Debasse M; Toelen J; Schoeters J; Lavend'homme R; Freson K; Peerlinck K
Int J Lab Hematol; 2017 Jun; 39(3):301-307. PubMed ID: 28318107
[TBL] [Abstract][Full Text] [Related]
76. Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male.
Kumar R; Dawson J; Varga E; Canini JT; Monda KL; Dunn AL
Pediatr Blood Cancer; 2019 Sep; 66(9):e27832. PubMed ID: 31131962
[TBL] [Abstract][Full Text] [Related]
77. A novel fibrinogen Bbeta chain frameshift mutation in a patient with severe congenital hypofibrinogenaemia.
Xu X; Wu J; Zhai Z; Zhou R; Wang X; Wang H; Ding K; Sun Z; Ni H
Thromb Haemost; 2006 Jun; 95(6):931-5. PubMed ID: 16732370
[TBL] [Abstract][Full Text] [Related]
78. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerization and peptide B release.
Mathonnet F; Guillon L; Detruit H; Mazmanian GM; Dreyfus M; Alvarez JC; Giudicelli Y; de Mazancourt P
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):293-8. PubMed ID: 12695754
[TBL] [Abstract][Full Text] [Related]
79. Fibrinogen and the risk of thrombosis.
de Moerloose P; Boehlen F; Neerman-Arbez M
Semin Thromb Hemost; 2010 Feb; 36(1):7-17. PubMed ID: 20391292
[TBL] [Abstract][Full Text] [Related]
80. [Not Available].
Bor MV
Ugeskr Laeger; 2024 Jan; 186(1):. PubMed ID: 38235772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
